Every day, stories about the U.S. opioid epidemic appear in daily newsfeeds, and rightly so: they are responsible for two out of every three drug overdoses in the country.
But there’s another drug not included in the usual drug overdose stats which kills almost twice as many people a year as opioids — alcohol. And yet, a casual perusal of the daily headlines usually turns up as many fun or fluff stories about alcohol as ones that suggest the risks and harms of drinking. Continue reading
The Federal Trade Commission and State of New York late last month filed a lawsuit against Martin Shkreli, charging that Shkreli and Vyera Pharmaceuticals raised the price of the life-saving drug Daraprim by more than 4,000% and worked to corner the market for such drugs.
“The joint action accused Shkreli and Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, of scheming to ‘illegally’ prevent would-be generic competitors from selling a version of Daraprim,” as Stat’s Ed Silverman reported on Jan. 27. After acquiring the drug in 2015, Shkreli, dubbed the “Pharma Bro,” and Turing raised the list price of the medication from $17.50 per tablet to $750, he added. Continue reading
Investigative journalist Katherine Eban will discuss her new book documenting rampant fraud in the generic drug industry during an AHCJ webcast on Wednesday, June 19.
In her book, “Bottle of Lies: The Inside Story of the Generic Drug Boom,” Eban reveals how generic drug makers not only help ensure that some of the worst quality drugs enter the least regulated markets but also take extreme measures to avoid regulatory scrutiny. Harper Collins/Ecco’s Hardcover division published the book on May 14. Continue reading
A panel of experts in geriatric care has identified nearly 100 medications that should be avoided or used with caution among the older population in the latest update to the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
The recommendations by the American Geriatrics Society are widely used by clinicians, educators, researchers, health care administrators and regulators to ensure medications are appropriately prescribed. Continue reading
Prescription rates of opioids and benzodiazepines are on the rise among the older adult population, according to two recent studies. And that is cause for concern, say researchers.
In one study, Greg Rhee, Ph.D., an adjunct assistant professor in the University of Minnesota College of Pharmacy, examined prescribing trends in outpatient settings of opioids and benzodiazepines. His analysis found that between 2006-07 and 2014-15, the prescription rates of benzodiazepine drugs such as Xanax and Halcion increased from 4.8 percent to 6.2 percent; the rate of prescription opioids alone increased from 5.9 percent to 10 percent, and the co-prescribing rate of both benzodiazepines and opioids increased over time from 1.1 percent to 2.7 percent, respectively. Continue reading
Photo: Pia Christensen/AHCJ
In April, the staff of the Cincinnati Enquirer won the 2018 Pulitzer Prize in Local Reporting for an extraordinary special project, “Seven Days of Heroin: This is what an epidemic looks like.” As the Pulitzer judges said, the newspaper’s staff won, “For a riveting and insightful narrative and video documenting seven days of greater Cincinnati’s heroin epidemic, revealing how the deadly addiction has ravaged families and communities.” The project’s video element earned an Edward R. Murrow award for excellence in video and a regional Emmy award. Continue reading